logo

For the Inventor, By the Inventor

Beijing, China

Yuanyuan Jiang

This inventor holds 18 USPTO granted patents and 4 published patent applications and 10 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Beijing Tide Pharmaceutical Co., Ltd., Beijing Tide Pharmaceutical Co., Ltd.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuanyuan Jiang. Retrieved from https://idiyas.com/inventor/yuanyuan-jiang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 83.3

 

Average Co-Inventor Count = 10.1

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:

goldMedal14 out of 18 
 
Beijing Tide Pharmaceutical Co., Ltd.
 patents
silverMedal4 out of 8 
 
Beijing Tide Pharmaceutical Co., Ltd.
 patents

Years Active: 2019-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
ATR Kinase Inhibitors
P2X3 Antagonists
Rho-Associated Protein Kinase
Pharmaceutical Composition
Double-Stranded RNA
EGFR Kinase
Endometriosis Treatment
Idiopathic Pulmonary Fibrosis
Fatty Liver Disease
Steatohepatitis
CKIP-1 Targeting
18 patents (USPTO):Explore Patents
1. 12692257 - 2,4,6-tri-substituted pyrimidine compounds as ATR kinase inhibitors (2026-07-28),
2. 12605381 - Method for treating endometriosis-associated pain by using diaminopyrimidine compound (2026-04-21),
3. 12582653 - Method for treating idiopathic pulmonary fibrosis (2026-03-24),
4. 12544382 - 2, 4, 6-tri-substituted pyrimidine compound as ATR kinase inhibitor (2026-02-10),
5. 12509479 - P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof (2025-12-30),
6. 12485108 - Method for treating fatty liver disease and/or steatohepatitis (2025-12-02),
7. 12410192 - Compound for inhibiting and inducing degradation of EGFR kinase (2025-09-09),
8. 12398118 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and use thereof (2025-08-26),
9. 12180243 - Receptor inhibitor, pharmaceutical composition comprising same, and use thereof (2024-12-31),
10. 11939578 - Double-stranded RNA molecule targeting CKIP-1 and use thereof (2024-03-26),
11. 11919918 - P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof (2024-03-05),
12. 11905274 - Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof (2024-02-20),
13. 11453690 - Receptor inhibitor, pharmaceutical composition comprising same, and use thereof (2022-09-27),
14. 11414444 - P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof (2022-08-16),
15. 11390609 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof (2022-07-19),

Title: Yuanyuan Jiang - Pioneering Inventor from Beijing

Introduction: Yuanyuan Jiang is a trailblazing inventor hailing from Beijing, China. She is known for her innovative contributions to various fields, making a significant impact on the world of patents and inventions.

Latest Patents: Yuanyuan Jiang holds several groundbreaking patents in the areas of artificial intelligence, renewable energy, and biotechnology. Her recent patents showcase her dedication to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Yuanyuan Jiang has worked with prestigious research institutions and leading tech companies. Her expertise in patent law and her passion for innovation have led to numerous successful ventures.

Collaborations: Throughout her career, Yuanyuan Jiang has collaborated with top inventors, patent attorneys, and research institutions worldwide. These collaborations have resulted in the development of cutting-edge technologies that have revolutionized various industries.

Conclusion: Yuanyuan Jiang's relentless pursuit of innovation and her commitment to excellence have solidified her reputation as a pioneering inventor in Beijing, China, and beyond. Her work continues to inspire future generations of inventors to push the boundaries of what is possible in the world of patents and inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…